Tryptamine, also known as 2-(3-indolyl)ethylamine, is an indolamine metabolite of the essential amino acid tryptophan. The chemical structure is defined by an indole, a fused benzene and pyrrole ring, and a 2-aminoethyl group at the second carbon (third aromatic carbon), and exhibits a primary aliphatic amine at C-2; molecular formula C10H12N2, molar mass 160.22 g mol-1, CAS 61-54-1. Chemically, the primary amino group is basic with a conjugate acid pKa in the low-to-mid single digits to around 9 to 10 depending on solvent and counterion, the indole ring provides UV absorbance near 280 nm and characteristic 1H and 13C NMR resonances in the aromatic region, and the compound forms stable crystalline or salt forms for analytical and handling purposes. Tryptamine is soluble in most organic solvents and sparingly soluble in water as the free base while readily forming water-soluble salts; it is commonly handled and characterized using HPLC, GC-MS, LC-MS and NMR in research and quality control contexts.
Parent: Serotonin / Tryptamine
Parent: Serotonin / Tryptamine
Typical specification targets for reagent or reference-grade tryptamine aim for an assay of 98.0 area percent or greater by validated HPLC methods, with total related impurities generally below 1.5 to 2.0 area percent; common related compounds and typical quantitative ranges observed depend on synthesis and purification but often include N-methyltryptamine (NMT) at about 0.1 to 1.0 percent, N,N-dimethyltryptamine (DMT) below 0.1 to 0.5 percent, residual indole or partially substituted indoles below 0.05 to 0.5 percent, tryptophol and indole-3-acetaldehyde type oxidation or degradation products in trace to 0.5 percent levels, and unreacted starting-material fragments typically under 1.0 percent. Typical ancillary quality limits include residual solvents below 0.5 percent, water content below 0.5 percent, and inorganic residue or chloride levels characterized to meet customer or pharmacopeial requirements. Identification and quantitation of these impurities are normally performed by orthogonal methods such as HPLC with UV and MS detection, GC-MS for volatile impurities, and 1H NMR for overall purity assessment.
Tryptamine serves as an endogenous trace amine and biochemical scaffold; it is a biosynthetic intermediate and metabolite in pathways related to serotonin and melatonin, and is used in laboratory research as a reference standard, as a core structural motif in medicinal chemistry programs, and in analytical studies of indole chemistry and receptor pharmacology.
Common tryptamine derivatives include tryptamine itself, N-methyltryptamine (NMT), N,N-dimethyltryptamine (DMT), 5-hydroxytryptamine (serotonin) as a biological derivative, 5-MeO-DMT and psilocin/psilocybin as methoxy or hydroxy-substituted derivatives; these differ by N-alkylation and ring substitution patterns that influence pharmacology and physicochemical properties.
Strength depends on the receptor and endpoint considered; among known derivatives, DMT and 5-MeO-DMT are often reported as highly potent at certain serotonin receptor subtypes in pharmacological assays, but potency varies by assay type, receptor subtype, route of exposure and experimental conditions, so comparative potency statements should reference specific receptor-binding or functional data.
Yes, DMT is N,N-dimethyltryptamine, a doubly N-alkylated derivative of the core tryptamine structure, sharing the indole-2-ethylamine backbone while bearing two methyl groups on the terminal amine.
